Skip to main content

Biotechnology

Growing with the Industry Since the '70s

​Mintz attorneys have been working with biotech innovators and investors since the birth of the industry in the '70s. We help entrepreneurs get businesses off the ground. Help growing companies get funded. Help public corporations remain compliant with SEC requirements. And help investors and underwriters secure positions in industry leaders. Our professionals are embedded in the biotech ecosystem, and our clients rely on us for solutions to a broad range of complex issues.

Sign up for insights

Share Awards
 

Our Experience

Case Study
Mintz has represented oncology-focused biotherapeutic company Inhibrx LP since its inception. Mintz attorneys have advised Inhibrx on licensing deals and financing deals involving unusual corporate and tax structuring and international aspects.
Case Study
In federal and state cases alleging a large pharmaceutical client and its co-developer failed to adequately warn regarding the risk of personal injury, Mintz delivered wins on every substantive issue, in every case, in every jurisdiction.
Case Study
Mintz’s work for synthetic biotic company Synlogic Inc. has included raising over $100 million in three VC financing rounds. Mintz attorneys also helped Synlogic form a multiyear global R&D collaboration with AbbVie and raise more than $40 million in an IPO via a reverse merger with Mirna Therapeutics.

Areas of Focus

Our Approach

​We take a collaborative approach to helping biotechnology companies advance their interests — bringing leading professionals from our transactions, IP, litigation, and regulatory practices together to provide comprehensive guidance and solutions.

Mintz helps researchers protect their innovations through the patent process. And we help protect products through the trademark and labeling regimes. We help companies and investors with their corporate and financing transactions and day-to-day corporate advisory work. And we help clinical trial teams develop programs and contracts that conform to FDA requirements. We also help increase clients' awareness of litigation risks before they launch products into the market — putting them in a better position when the inevitable litigation strikes their successful products.

FDA Regulation: Life Cycle Services
  • Approval pathways
  • Product development
  • Clinical research
  • Advertising and promotion
  • Compliance and enforcement
  • FDA interactions and disputes
  • Corporate transactions
  • Commercial relationships
​Corporate Counseling & Transactions
  • IPOs, follow-on offerings, and PIPE transactions
  • Reverse mergers, Form 10s, and APOs
  • Securities regulatory compliance
  • Corporate governance advice
  • Mergers and acquisitions
  • Strategic collaborations and licensing
  • Angel and venture capital financing
  • Equity compensation
​Intellectual Property Services
  • Patent prosecution and strategy
  • Patent infringement litigation
  • Hatch-Waxman Paragraph IV litigation
  • Alternative dispute resolution
  • Trademark strategy and registration

Meet Mintz

​Attorneys from our US and London offices collaborate to provide nimble solutions that help biotechs grow and succeed.